A Phase 2a Randomized Controlled Trial of MIB-626 ² Nicotinamide Mononucleotide, NMN versus Placebo in Adults with COVID-19 Infection and Early Acute Kidney Injury

Project: Other project

Project Details

StatusActive
Effective start/end date8/2/218/1/26